Selecting an Optimal Staging System for Intermediate-Stage Hepatocellular Carcinoma: Comparison of 9 Currently Used Prognostic Models
Yong-Fa Zhang,1,2,* Ming Shi,3,* Liang-He Lu,3 Lu Wang,1,2 Rong-Ping Guo3 1Department of Hepatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, People’s Republic of China; 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, People’s...
Main Authors: | Zhang YF, Shi M, Lu LH, Wang L, Guo RP |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-04-01
|
Series: | Journal of Hepatocellular Carcinoma |
Subjects: | |
Online Access: | https://www.dovepress.com/selecting-an-optimal-staging-system-for-intermediate-stage-hepatocellu-peer-reviewed-fulltext-article-JHC |
Similar Items
-
Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
by: Jun Young Kim, et al.
Published: (2016-06-01) -
Transarterial Chemoembolization Combined With Hepatectomy for the Treatment of Intermediate-Stage Hepatocellular Carcinoma
by: Qunfang Zhou, et al.
Published: (2020-11-01) -
Liver resection versus transarterial chemoembolization for the treatment of intermediate‐stage hepatocellular carcinoma
by: Shuling Chen, et al.
Published: (2019-04-01) -
Analyses of Intermediate-Stage Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization prior to Designing Clinical Trials
by: Keisuke Koroki, et al.
Published: (2020-07-01) -
Neutrophil-to-Lymphocyte Ratio as a Biomarker Predicting Overall Survival after Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma
by: Hee Ho Chu, et al.
Published: (2021-06-01)